Patient | Sex/Age | Followup, yrs | ILD | Myositis | RA-like Arthritis | Joint Erosions | Anti-ENA | Anti-CCP, IU/ml | RF, IU/ml |
---|---|---|---|---|---|---|---|---|---|
1 | M 78 | 4 | Yes | Yes | Yes | No | Jo-1/Ro | Neg | Neg |
2 | M 57 | 5 | Yes | No | No | No | Jo-1 | Neg | Neg |
3 | F 74 | 3 | Yes | Yes | Yes | No | Jo-1 | Neg | Neg |
4 | F 78 | 6 | Yes | No | Yes | No | Jo-1/Ro | Neg | 42 |
5 | M 73 | 4 | Yes | No | Yes | No | Jo-1/Ro | Neg | Neg |
6 | F 78 | 7 | Yes | Yes | Yes | No | Jo-1 | Neg | Neg |
7 | M 46 | 3 | Yes | Yes | Yes | Yes | Jo-1/Ro | 14 | 29 |
8 | F 56 | 9 | Yes | Yes | Yes | No | Jo-1/Ro | Neg | Neg |
9 | F 78 | 5 | Yes | Yes | Yes | No | Jo-1 | Neg | Neg |
10 | F 63 | 11 | Yes | Yes | Yes | No | Jo-1/Ro | Neg | Neg |
11 | F 57 | 10 | Yes | No | Yes | No | Jo-1 | Neg | Neg |
12 | F 62 | 3 | Yes | Yes | Yes | Yes | Jo-1 | 162 | 78 |
ILD: interstitial lung disease; RA: rheumatoid arthritis; ENA: extractable nuclear antigen antibodies; CCP: citric citrullinated peptide antibodies; RF: rheumatoid factor.